Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)

Walter Zingg; Julie Storr; Benjamin J. Park; John A. Jernigan; Stephan Harbarth; M. Lindsay Grayson; Evelina Tacconelli; Benedetta Allegranzi; Denise Cardo; Didier Pittet; Mohamed Abbas; Raheelah Ahmad; Antoine Andremont; Mike Bell; Michael Borg; Yehuda Carmeli; Enrique Castro-Sanchez; John Conly; Philippe Eggimann; Petra Gastmeier; Marcela Hernandez; Loreen Herwaldt; Alison Holmes; Claire Kilpatrick; Amy Kolwaite; Karl Heinz Krause; Elaine Larson; Sarah Masson-Roy; Shaheen Mehtar; Marc Mendelson; Ling Moi Lin; Andreea Moldovan; Dominique Monnet; Babacar Ndoye; Peter Nthumba; Folasade Ogunsola; Eli Perencevich; Matthew Samore; Wing Hong Seto; Arjun Srinivasan; Carolyn Tarrant; Sara Tomczyk; Maha Talaat; Maria Virginia Villegas; Andreas Voss; Tim Walsh; Andreas Widmer

doi:10.1186/s13756-019-0528-0

Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)

Walter Zingg, Julie Storr, Benjamin J. Park, John A. Jernigan, Stephan Harbarth, M. Lindsay Grayson, Evelina Tacconelli, Benedetta Allegranzi, Denise Cardo, Didier Pittet, Mohamed Abbas, Raheelah Ahmad, Antoine Andremont, Mike Bell, Michael Borg, Yehuda Carmeli, Enrique Castro-Sanchez, John Conly, Philippe Eggimann, Petra GastmeierMarcela Hernandez, Loreen Herwaldt, Alison Holmes, Claire Kilpatrick, Amy Kolwaite, Karl Heinz Krause, Elaine Larson, Sarah Masson-Roy, Shaheen Mehtar, Marc Mendelson, Ling Moi Lin, Andreea Moldovan, Dominique Monnet, Babacar Ndoye, Peter Nthumba, Folasade Ogunsola, Eli Perencevich, Matthew Samore, Wing Hong Seto, Arjun Srinivasan, Carolyn Tarrant, Sara Tomczyk, Maha Talaat, Maria Virginia Villegas, Andreas Voss, Tim Walsh, Andreas Widmer

School of Nursing

Résultat de recherche › examen par les pairs

6 Citations (Scopus)

Résumé

Background: Healthcare-associated infection (HAI) is a major challenge for patient safety worldwide, and is further complicated by antimicrobial resistance (AMR) due to excessive antimicrobial use in both humans and animals. Existing infection prevention and control (IPC) networks must be strengthened and adapted to better address the global challenges presented by emerging AMR. Methods: In June 2017, 42 international experts convened in Geneva, Switzerland, to discuss two key areas for strengthening the global IPC network: 1) broadening collaboration in IPC; and 2) how to bring the fields IPC and AMR control together. Results: The US Centers for Disease Prevention and Control, the European Centre for Disease Prevention and Control, and the World Health Organization (WHO) convened together with international experts to discuss collaboration and networks, demonstrating the participating organizations' commitment to close collaboration in IPC. The challenge of emerging AMR can only be addressed by strengthening this collaboration across international organisations and between public health and academia. The WHO SAVE LIVES: Clean Your Hands initiative is an example of a successful collaboration between multiple global stakeholders including academia and international public health organisations; it can be used as a model. IPC-strategies are included within the four pillars to combat AMR: surveillance, IPC, antimicrobial and diagnostic stewardship, research and development. The prevention of transmission of multidrug-resistant microorganisms is a patient safety issue, and must be strengthened in the fight against AMR. Conclusions: The working group determined that international organisations should take the lead in creating new networks, which will in turn attract academia and other stakeholders to join. At the same time, they should invest in bringing existing IPC and AMR networks under one umbrella. Transmission of multidrug-resistant microorganisms in hospitals and in the community threatens the success of antimicrobial stewardship programmes, and thus, research and development in IPC should be addressed as an enhanced global priority.

Langue d'origine	English
Numéro d'article	74
Journal	Antimicrobial Resistance and Infection Control
Volume	8
Numéro de publication	1
DOI	https://doi.org/10.1186/s13756-019-0528-0
Statut de publication	Published - mai 10 2019

Financement

AMA: American Medical Association; AMR: Antimicrobial resistance; ARHAI: Antimicrobial Resistance and Healthcare-Associated Infection (−network); CDC: US Centers for Disease Control and Prevention; EARSS: European Antimicrobial Resistance Surveillance System; EC: European Commission; ECDC: European Centre for Disease Prevention and Control; EFPIA: European Federation of Pharmaceutical Industries and Associations; EFSA: European Food Safety Authority; EIP: (CDC) Emerging Infections Program; ESAC: European Surveillance on Antimicrobial Consumption; EU: European Union; FDA: US Food and Drug Association; HAI: Healthcare-associated infection; HELICS: Hospitals in Europe Link for Infection Control through Surveillance; HUG: University of Geneva Hospitals; IMI: Innovative Medicines Initiative; IPC: Infection prevention and control; IPSE: Improving Patient Safety in Europe; JPIAMR: Joint Programming Initiative on Antimicrobial Resistance; LMIC: Low-and-middle-income country; NIH: US National Institutes of Health; OGHA: Office of Global Health Affairs; POPS: Private Organizations for Patient Safety; TATFAR: Trans-Atlantic Task Force on Antimicrobial Resistance; USDHS: US Department of Homeland Security; WHO: World Health Organization

Bailleurs de fonds	Numéro du bailleur de fonds
ESAC
European Antimicrobial Resistance Surveillance System
US Food and Drug Association
National Institutes of Health
Centers for Disease Control and Prevention
U.S. Food and Drug Administration
U.S. Department of Homeland Security
American Medical Association
Joint Programming Initiative on Antimicrobial Resistance
European Federation of Pharmaceutical Industries and Associations
European Food Safety Authority
European Commission
Hôpitaux Universitaires de Genève
Innovative Medicines Initiative

ASJC Scopus Subject Areas

Public Health, Environmental and Occupational Health
Microbiology (medical)
Infectious Diseases
Pharmacology (medical)

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1186/s13756-019-0528-0

Autres fichiers et liens

Citer

Zingg, W., Storr, J., Park, B. J., Jernigan, J. A., Harbarth, S., Grayson, M. L., Tacconelli, E., Allegranzi, B., Cardo, D., Pittet, D., Abbas, M., Ahmad, R., Andremont, A., Bell, M., Borg, M., Carmeli, Y., Castro-Sanchez, E., Conly, J., Eggimann, P., ... Widmer, A. (2019). Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3). Antimicrobial Resistance and Infection Control, 8(1), Article 74. https://doi.org/10.1186/s13756-019-0528-0

Zingg, W, Storr, J, Park, BJ, Jernigan, JA, Harbarth, S, Grayson, ML, Tacconelli, E, Allegranzi, B, Cardo, D, Pittet, D, Abbas, M, Ahmad, R, Andremont, A, Bell, M, Borg, M, Carmeli, Y, Castro-Sanchez, E, Conly, J, Eggimann, P, Gastmeier, P, Hernandez, M, Herwaldt, L, Holmes, A, Kilpatrick, C, Kolwaite, A, Krause, KH, Larson, E, Masson-Roy, S, Mehtar, S, Mendelson, M, Lin, LM, Moldovan, A, Monnet, D, Ndoye, B, Nthumba, P, Ogunsola, F, Perencevich, E, Samore, M, Seto, WH, Srinivasan, A, Tarrant, C, Tomczyk, S, Talaat, M, Villegas, MV, Voss, A, Walsh, T & Widmer, A 2019, 'Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)', Antimicrobial Resistance and Infection Control, vol. 8, n° 1, 74. https://doi.org/10.1186/s13756-019-0528-0

@article{707a8ecbd817434f8abb1e7f83bfcda8,

title = "Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)",

abstract = "Background: Healthcare-associated infection (HAI) is a major challenge for patient safety worldwide, and is further complicated by antimicrobial resistance (AMR) due to excessive antimicrobial use in both humans and animals. Existing infection prevention and control (IPC) networks must be strengthened and adapted to better address the global challenges presented by emerging AMR. Methods: In June 2017, 42 international experts convened in Geneva, Switzerland, to discuss two key areas for strengthening the global IPC network: 1) broadening collaboration in IPC; and 2) how to bring the fields IPC and AMR control together. Results: The US Centers for Disease Prevention and Control, the European Centre for Disease Prevention and Control, and the World Health Organization (WHO) convened together with international experts to discuss collaboration and networks, demonstrating the participating organizations' commitment to close collaboration in IPC. The challenge of emerging AMR can only be addressed by strengthening this collaboration across international organisations and between public health and academia. The WHO SAVE LIVES: Clean Your Hands initiative is an example of a successful collaboration between multiple global stakeholders including academia and international public health organisations; it can be used as a model. IPC-strategies are included within the four pillars to combat AMR: surveillance, IPC, antimicrobial and diagnostic stewardship, research and development. The prevention of transmission of multidrug-resistant microorganisms is a patient safety issue, and must be strengthened in the fight against AMR. Conclusions: The working group determined that international organisations should take the lead in creating new networks, which will in turn attract academia and other stakeholders to join. At the same time, they should invest in bringing existing IPC and AMR networks under one umbrella. Transmission of multidrug-resistant microorganisms in hospitals and in the community threatens the success of antimicrobial stewardship programmes, and thus, research and development in IPC should be addressed as an enhanced global priority.",

author = "Walter Zingg and Julie Storr and Park, {Benjamin J.} and Jernigan, {John A.} and Stephan Harbarth and Grayson, {M. Lindsay} and Evelina Tacconelli and Benedetta Allegranzi and Denise Cardo and Didier Pittet and Mohamed Abbas and Raheelah Ahmad and Antoine Andremont and Mike Bell and Michael Borg and Yehuda Carmeli and Enrique Castro-Sanchez and John Conly and Philippe Eggimann and Petra Gastmeier and Marcela Hernandez and Loreen Herwaldt and Alison Holmes and Claire Kilpatrick and Amy Kolwaite and Krause, {Karl Heinz} and Elaine Larson and Sarah Masson-Roy and Shaheen Mehtar and Marc Mendelson and Lin, {Ling Moi} and Andreea Moldovan and Dominique Monnet and Babacar Ndoye and Peter Nthumba and Folasade Ogunsola and Eli Perencevich and Matthew Samore and Seto, {Wing Hong} and Arjun Srinivasan and Carolyn Tarrant and Sara Tomczyk and Maha Talaat and Villegas, {Maria Virginia} and Andreas Voss and Tim Walsh and Andreas Widmer",

note = "Publisher Copyright: {\textcopyright} 2019 The Author(s).",

year = "2019",

month = may,

day = "10",

doi = "10.1186/s13756-019-0528-0",

language = "English",

volume = "8",

journal = "Antimicrobial Resistance and Infection Control",

issn = "2047-2994",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)

AU - Zingg, Walter

AU - Storr, Julie

AU - Park, Benjamin J.

AU - Jernigan, John A.

AU - Harbarth, Stephan

AU - Grayson, M. Lindsay

AU - Tacconelli, Evelina

AU - Allegranzi, Benedetta

AU - Cardo, Denise

AU - Pittet, Didier

AU - Abbas, Mohamed

AU - Ahmad, Raheelah

AU - Andremont, Antoine

AU - Bell, Mike

AU - Borg, Michael

AU - Carmeli, Yehuda

AU - Castro-Sanchez, Enrique

AU - Conly, John

AU - Eggimann, Philippe

AU - Gastmeier, Petra

AU - Hernandez, Marcela

AU - Herwaldt, Loreen

AU - Holmes, Alison

AU - Kilpatrick, Claire

AU - Kolwaite, Amy

AU - Krause, Karl Heinz

AU - Larson, Elaine

AU - Masson-Roy, Sarah

AU - Mehtar, Shaheen

AU - Mendelson, Marc

AU - Lin, Ling Moi

AU - Moldovan, Andreea

AU - Monnet, Dominique

AU - Ndoye, Babacar

AU - Nthumba, Peter

AU - Ogunsola, Folasade

AU - Perencevich, Eli

AU - Samore, Matthew

AU - Seto, Wing Hong

AU - Srinivasan, Arjun

AU - Tarrant, Carolyn

AU - Tomczyk, Sara

AU - Talaat, Maha

AU - Villegas, Maria Virginia

AU - Voss, Andreas

AU - Walsh, Tim

AU - Widmer, Andreas

PY - 2019/5/10

Y1 - 2019/5/10

N2 - Background: Healthcare-associated infection (HAI) is a major challenge for patient safety worldwide, and is further complicated by antimicrobial resistance (AMR) due to excessive antimicrobial use in both humans and animals. Existing infection prevention and control (IPC) networks must be strengthened and adapted to better address the global challenges presented by emerging AMR. Methods: In June 2017, 42 international experts convened in Geneva, Switzerland, to discuss two key areas for strengthening the global IPC network: 1) broadening collaboration in IPC; and 2) how to bring the fields IPC and AMR control together. Results: The US Centers for Disease Prevention and Control, the European Centre for Disease Prevention and Control, and the World Health Organization (WHO) convened together with international experts to discuss collaboration and networks, demonstrating the participating organizations' commitment to close collaboration in IPC. The challenge of emerging AMR can only be addressed by strengthening this collaboration across international organisations and between public health and academia. The WHO SAVE LIVES: Clean Your Hands initiative is an example of a successful collaboration between multiple global stakeholders including academia and international public health organisations; it can be used as a model. IPC-strategies are included within the four pillars to combat AMR: surveillance, IPC, antimicrobial and diagnostic stewardship, research and development. The prevention of transmission of multidrug-resistant microorganisms is a patient safety issue, and must be strengthened in the fight against AMR. Conclusions: The working group determined that international organisations should take the lead in creating new networks, which will in turn attract academia and other stakeholders to join. At the same time, they should invest in bringing existing IPC and AMR networks under one umbrella. Transmission of multidrug-resistant microorganisms in hospitals and in the community threatens the success of antimicrobial stewardship programmes, and thus, research and development in IPC should be addressed as an enhanced global priority.

AB - Background: Healthcare-associated infection (HAI) is a major challenge for patient safety worldwide, and is further complicated by antimicrobial resistance (AMR) due to excessive antimicrobial use in both humans and animals. Existing infection prevention and control (IPC) networks must be strengthened and adapted to better address the global challenges presented by emerging AMR. Methods: In June 2017, 42 international experts convened in Geneva, Switzerland, to discuss two key areas for strengthening the global IPC network: 1) broadening collaboration in IPC; and 2) how to bring the fields IPC and AMR control together. Results: The US Centers for Disease Prevention and Control, the European Centre for Disease Prevention and Control, and the World Health Organization (WHO) convened together with international experts to discuss collaboration and networks, demonstrating the participating organizations' commitment to close collaboration in IPC. The challenge of emerging AMR can only be addressed by strengthening this collaboration across international organisations and between public health and academia. The WHO SAVE LIVES: Clean Your Hands initiative is an example of a successful collaboration between multiple global stakeholders including academia and international public health organisations; it can be used as a model. IPC-strategies are included within the four pillars to combat AMR: surveillance, IPC, antimicrobial and diagnostic stewardship, research and development. The prevention of transmission of multidrug-resistant microorganisms is a patient safety issue, and must be strengthened in the fight against AMR. Conclusions: The working group determined that international organisations should take the lead in creating new networks, which will in turn attract academia and other stakeholders to join. At the same time, they should invest in bringing existing IPC and AMR networks under one umbrella. Transmission of multidrug-resistant microorganisms in hospitals and in the community threatens the success of antimicrobial stewardship programmes, and thus, research and development in IPC should be addressed as an enhanced global priority.

UR - http://www.scopus.com/inward/record.url?scp=85065613548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065613548&partnerID=8YFLogxK

U2 - 10.1186/s13756-019-0528-0

DO - 10.1186/s13756-019-0528-0

M3 - Article

C2 - 31168366

AN - SCOPUS:85065613548

SN - 2047-2994

VL - 8

JO - Antimicrobial Resistance and Infection Control

JF - Antimicrobial Resistance and Infection Control

IS - 1

M1 - 74

ER -

Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)

Résumé

Financement

ASJC Scopus Subject Areas

ODD de l’ONU

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer